Alder BioPharmaceuticals (ALDR) Misses Q1 EPS by 1c

Alder BioPharmaceuticals (NASDAQ: ALDR) reported Q1 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Alder BioPharmaceuticals (ALDR) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating